European Management of Glanzmann’s Thrombasthenia from EAHAD’s Working Group
European Association for Haemophilia and Allied Disorders (EAHAD) shared on LinkedIn:
”Care for Glanzmann’s thrombasthenia still varies widely across Europe, from antibody screening practices to access to HLA-matched platelets.
A new publication from the EAHAD Glanzmann Thrombasthenia Working Group highlights areas of agreement and where further alignment is needed.
Read more on the Haemophilia Journal.”
Read the full article in Haemophilia Journal.
Article: European Management of Glanzmann’s Thrombasthenia: A Survey of Current Clinical Practice
Authors: Mathieu Fiore, Andrea Artoni, Robert Klamroth, Mary Mathias, Roger Schutgens, Roseline d’Oiron, EAHAD Glanzmann Thrombasthenia Working Group
Stay updated on all scientific advances in the field of platelet disorders with Hemostasis Today.
-
Jul 26, 2026, 08:51Dayita Banerjee: Presenting New Insights in Fibrinolysis Research at ISTH 2026
-
Jul 26, 2026, 08:39Roshni Kulkarni: The Human Face of Postpartum Hemorrhage
-
Jul 26, 2026, 08:14Atahar imam Hasan: Universal Artificial Blood and the Future of Trauma Care
-
Jul 26, 2026, 07:40Maha Othman: Leading Scientific Collaboration Across Hemostasis at ISTH 2026
-
Jul 26, 2026, 07:20Pablo Corral: Why Should Dyslipidemia Be Any Different?
-
Jul 26, 2026, 06:46Marios Georgakis: Largest GWAS of Transient Ischemic Attacks Reveals New Genetic Insights into Stroke Risk
-
Jul 26, 2026, 06:40Aaron Iding: From Virtual Meetings to Meaningful Connections at ISTH 2026
-
Jul 26, 2026, 06:36How Stroke Services Have Evolved Over the Past 8 Years in Kazakhstan – International Journal of Stroke
-
Jul 26, 2026, 06:31Leonardo Roever: Non-LDL Biomarkers and The Potential Future Applications for 2ry Stroke Prevention